N/A
N=1,507
Consumer Perceptions of Waterpipe Tobacco Packaging and Digital Marketing Claims
Waterpipe Tobacco Smoking
Bottom Line
View on ClinicalTrials.gov: NCT05439421 ↗Enrolled (actual)
1,507
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcome: Primary: Willingness to Try Hookah Tobacco (Packaging Task ) — 1.9; 1.87; 1.9; 1.63 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Package/Advertisement With Claim (Behavioral); Package/Advertisement Without Claim (Behavioral)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Wake Forest University Health Sciences
- Primary completion
- Nov 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Willingness to Try Hookah Tobacco (Packaging Task ) |
1.9; 1.87; 1.9; 1.63; 1.95; 1.78 | — |
| PRIMARY Willingness to Smoke Hookah Tobacco (Digital Marketing Task ) |
1.74; 1.78; 1.46; 1.42; 1.67; 1.75 | — |
Summary
The purpose of the study is to evaluate the impact of marketing claims commonly found on waterpipe, also known as hookah, tobacco packages and in digital marketing on young adults' willingness to try hookah tobacco. Participants will complete two tasks, in random order. Participants will view six sample waterpipe tobacco packages, randomized at the package level to contain a prohibited or potentially-prohibited claim or not (Packaging Task). In the other task, they will view 10 digital marketing advertisements (i.e. Instagram posts or website pages) either with or without prohibited or potentially-prohibited claim, randomized at the advertisements level (Digital Marketing Task).
Eligibility Criteria
Inclusion Criteria
- United States (U.S.) Resident
- Has used waterpipe tobacco within the past year (self-report)
- Has not used waterpipe tobacco within the past year but it susceptible to use (self- report)
Exclusion Criteria
- Younger than 18 or older than 29
- Non U.S. Resident
- Has not used waterpipe tobacco within in the past year and is not susceptible to use (self-report)
Data sourced from ClinicalTrials.gov (NCT05439421). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.